CA’s Office of Statewide Health Planning and Development (OSHPD) Patient Hospital Discharge Data
This is a comprehensive data source for every inpatient hospital discharge at a licensed general acute care hospital in California (excluding the VA). The reported data includes patient demographic information (e.g. age, sex, county of residence, and race/ethnicity), diagnostic information (discharges using ICD9 codes), treatment information, total charges and expected source of payment. Available data dates back to 1997, and data is collected yearly.
The OSHPD data is useful for looking at disease incidence (particularly rare diseases) at the state level (or county level) for a particular year or within a certain time-span since the discharge code(s) can easily provide this information. For example, we can use the OSHPD data to look at changes in incidence of salmonella infections and costs associated with these infections from 2005-2010 in Los Angeles County. One problem with using OSHPD data is hospital readmissions are counted as unique discharges. Therefore, using counts of hospital discharges may not accurately represent the true number of cases.
It is difficult to make sound causal interpretations of studies using this data source. For example, a question such as “what the association between type 2 diabetes and myocardial infarction” would be very difficult to answer. Information on patient’s current health status would not be available, and there may be unmeasured confounding factors that can affect this association. A better data source would be from a healthcare provider like Kaiser where we have comprehensive medical history of each patient.
Multi-Ethnic Study of Atherosclerosis (MESA)
MESA is a longitudinal study (2000-2011) on the characteristics and risk factors of subclinical cardiovascular disease among different races/ethnicities (African Americans, Whites, Chinese-Americans, and Hispanics). A variety of data was collected, including biological, sociodemographic, life habits, psychosocial, etc.
The unique features of MESA’s data allow us to examine associations between race/ethnicity, risk factors, and cardiovascular outcomes. One possible question is: How does race/ethnicity modify the association between kidney disease and progression to incident cardiovascular disease? Comprehensive baseline data on cardiovascular and kidney health is available, and using this information we can also determine participants who were free of prevalent CVD at baseline. The longitudinal nature of the data follows these participants over time until their first CVD event, if it occurs at all, and using this information we can determine if the time to event differs between races/ethnicities.
All of MESA’s participants were middle-age or older at time of enrollment (age ranges from 45-84 years). Therefore, questions about exposures earlier in life typically cannot be answered using MESA. For example, a question such as “Does binge drinking among young adults increase risk of cardiovascular disease later in life” requires information on exposures during youth. This information may not be available in MESA, and if it is it would be based on participant recall, which is prone to recall bias. An appropriate study for this would be the Coronary Artery Risk Development in Young Adults (CARDIA) Study. This study enrolled young adults (ages 18-24 and 25-30) and aims to follow them for 30 years.
Study of Osteoporotic Fractures
SOF is a longitudinal study (16 years) that originally focused on risk factors and falls among non-Hispanic white women over 65 years of age (African American women were later also enrolled into the study), but has expanded to explore the process of aging in older women. Data collected includes medical history, anthropometric measures, cognitive and physical function, biologic measures, etc.
As this is a study consisting of older women, the data available makes it especially appropriate for answering questions related to aging. For example, SOF is a good data source to explore the question “What is the association between changes in physical function and cognitive decline?” SOF data includes longitudinal measures of both physical and cognitive functions, along with many other variables that can be possible confounders in this association (e.g. heart disease, diabetes, depression).
However, SOF cannot be used to explore gender differences. For example, “Does decline in physical function affect cognitive functioning differently in men and women?” would not be an appropriate question for SOF since the study only consists of women. One possible alternative is the Sacramento Area Latino Study on Aging (SALSA). In this study, Mexican-American men and women were followed yearly for ten years and underwent clinical, cognitive, and functional assessments at each follow-up. With SALSA, we can examine gender differences in the association between changes in physical function and cognitive decline. Since assessments were conducted yearly, incremental changes in both physical and cognitive function were more likely to be captured. It is worth noting, however, that the results may not be generalizable since the study consists of only Hispanic older adults.